Star Combo Pharma Ltd
ASX:S66
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.1
0.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one S66 stock under the Base Case scenario is 0.13 AUD. Compared to the current market price of 0.12 AUD, Star Combo Pharma Ltd is Undervalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Star Combo Pharma Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for S66 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Star Combo Pharma Ltd
Balance Sheet Decomposition
Star Combo Pharma Ltd
Current Assets | 18.4m |
Cash & Short-Term Investments | 7.4m |
Receivables | 4.5m |
Other Current Assets | 6.5m |
Non-Current Assets | 24.5m |
PP&E | 23.1m |
Intangibles | 677.2k |
Other Non-Current Assets | 684.7k |
Current Liabilities | 4.9m |
Accounts Payable | 4m |
Accrued Liabilities | 437.5k |
Other Current Liabilities | 385.4k |
Non-Current Liabilities | 4.6m |
Long-Term Debt | 3.9m |
Other Non-Current Liabilities | 747.9k |
Earnings Waterfall
Star Combo Pharma Ltd
Revenue
|
26.3m
AUD
|
Cost of Revenue
|
-20.3m
AUD
|
Gross Profit
|
6m
AUD
|
Operating Expenses
|
-4.8m
AUD
|
Operating Income
|
1.2m
AUD
|
Other Expenses
|
-436.4k
AUD
|
Net Income
|
747.3k
AUD
|
Free Cash Flow Analysis
Star Combo Pharma Ltd
AUD | |
Free Cash Flow | AUD |
S66 Profitability Score
Profitability Due Diligence
Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
S66 Solvency Score
Solvency Due Diligence
Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
S66 Price Targets Summary
Star Combo Pharma Ltd
Dividends
Current shareholder yield for S66 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-16. The firm develops, manufactures, and distributes a range of branded vitamins, dietary supplements, and skincare products, serving both domestic and offshore markets. The firm operates through two segments: Star Combo business and Austoyou retail. Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skin care products. Austoyou retail business made up of the Australia-China e-commerce platform that offers products directly to Chinese health product consumers; and Koala Mall’s two retail stores in Sydney. Its products include Costar NMN, Costar osteo comples Gluco, Living Healthy and Little, Amax Top Marine Collagen E ,J&K Ultra nourishing colla and J&K Rose Oil Lanolin Cream. The company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance.
Contact
IPO
Employees
Officers
The intrinsic value of one S66 stock under the Base Case scenario is 0.13 AUD.
Compared to the current market price of 0.12 AUD, Star Combo Pharma Ltd is Undervalued by 10%.